During the past decade, University of Pittsburgh, Alzheimer's Disease Research Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Pittsburgh, Alzheimer's Disease Research Center" #1 sponsor was "OPKO Health, Inc." with 2 trials, followed by "FUJIFILM Toyama Chemical Co., Ltd." with 1 trials sponsored, "National Institute on Aging (NIA)" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "University of Pittsburgh" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Pittsburgh, Alzheimer's Disease Research Center" #1 collaborator was "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 1 trials as a collaborator and "Johns Hopkins University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of Pittsburgh, Alzheimer's Disease Research Center" are "Alzheimer's Disease" (4 trials), "Alzheimer Disease" (2 trials), "Cognitive Impairment" (1 trials), "Dementia" (1 trials) and "Parkinson Disease" (1 trials). Many other conditions were trialed in "University of Pittsburgh, Alzheimer's Disease Research Center" in a lesser frequency.

Most popular intervention types in "University of Pittsburgh, Alzheimer's Disease Research Center" are "Drug" (6 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AZD0530 100mg daily" (1 trials), "AZD0530 125mg daily" (1 trials), "ELND005" (1 trials) and "ELND005 (scyllo-inositol)" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Pittsburgh, Alzheimer's Disease Research Center" are 7 trials for "All" genders.

Currently, there are NaN active trials in "University of Pittsburgh, Alzheimer's Disease Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in University of Pittsburgh, Alzheimer's Disease Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Pittsburgh, Alzheimer's Disease Research Center, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".